Evidence map›Paper›PMID 39779220›Full record

ReviewLife science alliance2025

Divergent destinies: insights into the molecular mechanisms underlying EPI and PE fate determination.

Paraskevi Athanasouli, Tijs Vanhessche, Frederic Lluis

Abstract readReview
In one paragraph

Review in Life science alliance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paraskevi AthanasouliDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, Leuven, Belgium paraskevi.athanasouli@kuleuven.be.ORCID 0000-0001-9504-7562
Tijs VanhesscheDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, Leuven, Belgium.ORCID 0000-0003-4196-6357
Frederic LluisDepartment of Development and Regeneration, Stem Cell Institute, KU Leuven, Leuven, Belgium frederic.lluisvinas@kuleuven.be.ORCID 0000-0002-7296-7611

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammalian pre-implantation development is entirely devoted to the specification of extra-embryonic lineages, which are fundamental for embryo morphogenesis and support. The second fate decision is taken just before implantation, as defined by the epiblast (EPI) and the primitive endoderm (PE) specification. Later, EPI forms the embryo proper and PE contributes to the formation of the yolk sac. The formation of EPI and PE as molecularly and morphologically distinct lineages is the final step of a multistage process, which begins when bipotent progenitor cells diverge into separate fates. Despite advances in uncovering the molecular mechanisms underlying the differential transcriptional patterns that dictate how apparently identical cells make fate decisions and how lineage integrity is maintained, a detailed overview of these mechanisms is still lacking. In this review, we dissect the EPI and PE formation process into four stages (initiation, specification, segregation, and maintenance) and we provide a comprehensive understanding of the molecular mechanisms involved in lineage establishment in the mouse. In addition, we discuss the conservation of key processes in humans, based on the most recent findings.

Indexed as

Cell DifferentiationCell LineageEmbryonic DevelopmentEndodermGene Expression Regulation, DevelopmentalGerm LayersAnimalsEmbryo, MammalianHumansMiceYolk Sac

Identifiers

PMID39779220
PMCPMC11711469

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.